THOUGHT LEADERSHIP

This year, PROMETRIKA team members have attended many industry conferences in which the hot topics always seem to be AI and automation of processes. Of course, the innovation cool crowd is excited to jump on board. What has really piqued my attention are the discussions amongst technology vendors about automating SDTM mapping. PROMETRIKA, as a full-service CRO, has a strong focus on biostatistics, statistical, and SDTM programming. Since SDTM mapping is a major part of the programming work that we do, I asked myself “Do we need a new business model for automating SDTM programming?” After hearing multiple viewpoints on the subject, I’ve come away with a list of pros and cons of automating SDTM mapping.

Buzzwords like “analytics” and “visualization” have been used in the clinical trial space since the ability to collect massive quantities of clinical trial data became a reality. Everyone wants the instant gratification of real-time trend detection, and software developers have responded in kind by providing a dizzying array of analytics options. How do you make an informed decision about which option is the right fit?

PROMETRIKA was honored to be invited back to sponsor the American Kidney Fund’s Pairing for Prevention fundraising event.

Companies that specialize in drugs for the treatment of rare diseases face a number of unique challenges during the development lifecycle of their products.

PROMETRIKA was the first Medidata CRO partner accredited in the Medidata Patient Cloud® platform.